Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 171

1.

Efficacy of Delayed Therapy with Fosmanogepix (APX001) in a Murine Model of Candida auris Invasive Candidiasis.

Wiederhold NP, Najvar LK, Shaw KJ, Jaramillo R, Patterson H, Olivo M, Catano G, Patterson TF.

Antimicrob Agents Chemother. 2019 Aug 19. pii: AAC.01120-19. doi: 10.1128/AAC.01120-19. [Epub ahead of print]

2.

Extended-Interval Dosing of Rezafungin against Azole-Resistant Aspergillus fumigatus.

Wiederhold NP, Najvar LK, Jaramillo R, Olivo M, Wickes BL, Catano G, Patterson TF.

Antimicrob Agents Chemother. 2019 Aug 12. pii: AAC.01165-19. doi: 10.1128/AAC.01165-19. [Epub ahead of print]

3.

Impact of the major Candida glabrata triazole resistance determinants on the activity of the novel investigational tetrazoles VT-1598 and VT-1161.

Nishimoto AT, Whaley SG, Wiederhold NP, Zhang Q, Yates CM, Hoekstra WJ, Schotzinger RJ, Garvey EP, Rogers PD.

Antimicrob Agents Chemother. 2019 Aug 5. pii: AAC.01304-19. doi: 10.1128/AAC.01304-19. [Epub ahead of print]

PMID:
31383660
4.

Development of High-Level Echinocandin Resistance in a Patient With Recurrent Candida auris Candidemia Secondary to Chronic Candiduria.

Biagi MJ, Wiederhold NP, Gibas C, Wickes BL, Lozano V, Bleasdale SC, Danziger L.

Open Forum Infect Dis. 2019 Jun 1;6(7):ofz262. doi: 10.1093/ofid/ofz262. eCollection 2019 Jul.

5.

Rasamsonia sp: An emerging infection amongst chronic granulomatous disease patients. A case of disseminated infection by a putatively novel Rasamsonia argillacea species complex involving the heart.

Babiker A, Gupta N, Gibas CFC, Wiederhold NP, Sanders C, Mele J, Fan H, Iovleva A, Haidar G, Fernandes C.

Med Mycol Case Rep. 2019 Apr 16;24:54-57. doi: 10.1016/j.mmcr.2019.04.002. eCollection 2019 Jun.

6.

Mutations in hmg1, Challenging the Paradigm of Clinical Triazole Resistance in Aspergillus fumigatus.

Rybak JM, Ge W, Wiederhold NP, Parker JE, Kelly SL, Rogers PD, Fortwendel JR.

MBio. 2019 Apr 2;10(2). pii: e00437-19. doi: 10.1128/mBio.00437-19.

7.

In Vitro Activities of the Novel Investigational Tetrazoles VT-1161 and VT-1598 Compared to the Triazole Antifungals against Azole-Resistant Strains and Clinical Isolates of Candida albicans.

Nishimoto AT, Wiederhold NP, Flowers SA, Zhang Q, Kelly SL, Morschhäuser J, Yates CM, Hoekstra WJ, Schotzinger RJ, Garvey EP, Rogers PD.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e00341-19. doi: 10.1128/AAC.00341-19. Print 2019 Jun.

PMID:
30910896
8.

Gastrointestinal pythiosis with concurrent presumptive gastrointestinal basidiobolomycosis in a Boxer dog.

Parambeth JC, Lawhon SD, Mansell J, Wu J, Clark SD, Sutton D, Gibas C, Wiederhold NP, Myers AN, Johnson MC, Levine GJ, Schlemmer S, Ruoff C, Isaiah A, Creevy KE.

Vet Clin Pathol. 2019 Mar;48(1):83-88. doi: 10.1111/vcp.12720. Epub 2019 Mar 21.

PMID:
30897244
9.

From the Clinical Mycology Laboratory: New Species and Changes in Fungal Taxonomy and Nomenclature.

Wiederhold NP, Gibas CFC.

J Fungi (Basel). 2018 Dec 16;4(4). pii: E138. doi: 10.3390/jof4040138. Review.

10.

The Fungal Cyp51-Specific Inhibitor VT-1598 Demonstrates In Vitro and In Vivo Activity against Candida auris.

Wiederhold NP, Lockhart SR, Najvar LK, Berkow EL, Jaramillo R, Olivo M, Garvey EP, Yates CM, Schotzinger RJ, Catano G, Patterson TF.

Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e02233-18. doi: 10.1128/AAC.02233-18. Print 2019 Mar.

11.

Novel Paranannizziopsis species in a Wagler's viper (Tropidolaemus wagleri), tentacled snakes (Erpeton tentaculatum), and a rhinoceros snake (Rhynchophis boulengeri) in a zoological collection.

Rainwater KL, Wiederhold NP, Sutton DA, Garner MM, Maguire C, Sanders C, Gibas C, Cano JF, Guarro J, Stchigel AM.

Med Mycol. 2019 Oct 1;57(7):825-832. doi: 10.1093/mmy/myy134.

PMID:
30520962
12.

Molecular diagnostics in medical mycology.

Wickes BL, Wiederhold NP.

Nat Commun. 2018 Dec 3;9(1):5135. doi: 10.1038/s41467-018-07556-5. Review.

13.

Examination of Fluconazole-Induced Alopecia in an Animal Model and Human Cohort.

Thompson GR 3rd, Krois CR, Affolter VK, Everett AD, Varjonen EK, Sharon VR, Singapuri A, Dennis M, McHardy I, Yoo HS, Fedor DM, Wiederhold NP, Aaron PA, Gelli A, Napoli JL, White SD.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e01384-18. doi: 10.1128/AAC.01384-18. Print 2019 Feb.

14.

In Vivo Efficacy of VT-1129 against Experimental Cryptococcal Meningitis with the Use of a Loading Dose-Maintenance Dose Administration Strategy.

Wiederhold NP, Xu X, Wang A, Najvar LK, Garvey EP, Ottinger EA, Alimardanov A, Cradock J, Behnke M, Hoekstra WJ, Brand SR, Schotzinger RJ, Jaramillo R, Olivo M, Kirkpatrick WR, Patterson TF.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01315-18. doi: 10.1128/AAC.01315-18. Print 2018 Nov.

15.

Screening a Repurposing Library for Inhibitors of Multidrug-Resistant Candida auris Identifies Ebselen as a Repositionable Candidate for Antifungal Drug Development.

Wall G, Chaturvedi AK, Wormley FL Jr, Wiederhold NP, Patterson HP, Patterson TF, Lopez-Ribot JL.

Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: e01084-18. doi: 10.1128/AAC.01084-18. Print 2018 Oct.

16.

In Vitro Activity of Isavuconazole against Opportunistic Fungal Pathogens from Two Mycology Reference Laboratories.

Pfaller MA, Rhomberg PR, Wiederhold NP, Gibas C, Sanders C, Fan H, Mele J, Kovanda LL, Castanheira M.

Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: e01230-18. doi: 10.1128/AAC.01230-18. Print 2018 Oct.

17.

Rezafungin (CD101) demonstrates potent in vitro activity against Aspergillus, including azole-resistant Aspergillus fumigatus isolates and cryptic species.

Wiederhold NP, Locke JB, Daruwala P, Bartizal K.

J Antimicrob Chemother. 2018 Nov 1;73(11):3063-3067. doi: 10.1093/jac/dky280.

PMID:
30032217
18.

The Fungal Cyp51 Inhibitor VT-1129 Is Efficacious in an Experimental Model of Cryptococcal Meningitis.

Wiederhold NP, Najvar LK, Garvey EP, Brand SR, Xu X, Ottinger EA, Alimardanov A, Cradock J, Behnke M, Hoekstra WJ, Schotzinger RJ, Jaramillo R, Olivo M, Kirkpatrick WR, Patterson TF.

Antimicrob Agents Chemother. 2018 Aug 27;62(9). pii: e01071-18. doi: 10.1128/AAC.01071-18. Print 2018 Sep.

19.

The Orotomide Olorofim Is Efficacious in an Experimental Model of Central Nervous System Coccidioidomycosis.

Wiederhold NP, Najvar LK, Jaramillo R, Olivo M, Birch M, Law D, Rex JH, Catano G, Patterson TF.

Antimicrob Agents Chemother. 2018 Aug 27;62(9). pii: e00999-18. doi: 10.1128/AAC.00999-18. Print 2018 Sep.

20.

Invasive Rhinosinusitis Caused by Lasiodiplodia theobromae in an Allogeneic Hematopoietic Cell Transplant Recipient Case Report and Review of Literature.

Rodriguez A, Anjan S, Martinez OV, Lekakis LJ, Beitinjaneh A, Camargo JF, Gibas CFC, Sanders CJ, Wiederhold NP, Abbo LM.

Mycopathologia. 2018 Oct;183(5):841-845. doi: 10.1007/s11046-018-0262-9. Epub 2018 Jun 22. Review.

PMID:
29934879
21.

Blastomyces helicus, a New Dimorphic Fungus Causing Fatal Pulmonary and Systemic Disease in Humans and Animals in Western Canada and the United States.

Schwartz IS, Wiederhold NP, Hanson KE, Patterson TF, Sigler L.

Clin Infect Dis. 2019 Jan 7;68(2):188-195. doi: 10.1093/cid/ciy483.

22.

Corrigendum: Fungal infections in animals: a patchwork of different situations.

Seyedmousavi S, Bosco SMG, de Hoog S, Ebel F, Elad D, Gomes RR, Jacobsen ID, Jensen HE, Martel A, Mignon B, Pasmans F, Piecková E, Rodrigues AM, Singh K, Vicente VA, Wibbelt G, Wiederhold NP, Guillot J.

Med Mycol. 2018 Nov 1;56(8):e4. doi: 10.1093/mmy/myy028. No abstract available.

PMID:
29672727
23.

Emergomyces canadensis, a Dimorphic Fungus Causing Fatal Systemic Human Disease in North America.

Schwartz IS, Sanche S, Wiederhold NP, Patterson TF, Sigler L.

Emerg Infect Dis. 2018 Apr;24(4):758-761. doi: 10.3201/eid2404.171765.

24.

Fungal infections in animals: a patchwork of different situations.

Seyedmousavi S, Bosco SMG, de Hoog S, Ebel F, Elad D, Gomes RR, Jacobsen ID, Jensen HE, Martel A, Mignon B, Pasmans F, Piecková E, Rodrigues AM, Singh K, Vicente VA, Wibbelt G, Wiederhold NP, Guillot J.

Med Mycol. 2018 Apr 1;56(suppl_1):165-187. doi: 10.1093/mmy/myx104. Review. Erratum in: Med Mycol. 2018 Nov 1;56(8):e4.

25.

Erratum for Mor et al., "Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids".

Mor V, Rella A, Farnoud AM, Singh A, Munshi M, Bryan A, Naseem S, Konopka JB, Ojima I, Bullesbach E, Ashbaugh A, Linke MJ, Cushion M, Collins M, Ananthula HK, Sallans L, Desai PB, Wiederhold NP, Fothergill AW, Kirkpatrick WR, Patterson T, Wong LH, Sinha S, Giaever G, Nislow C, Flaherty P, Pan X, Cesar GV, de Melo Tavares P, Frases S, Miranda K, Rodrigues ML, Luberto C, Nimrichter L, Del Poeta M.

MBio. 2018 Mar 13;9(2). pii: e00188-18. doi: 10.1128/mBio.00188-18. No abstract available.

26.

Reduced Antifungal Susceptibility of Vulvovaginal Candida Species at Normal Vaginal pH Levels: Clinical Implications.

Spitzer M, Wiederhold NP.

J Low Genit Tract Dis. 2018 Apr;22(2):152-158. doi: 10.1097/LGT.0000000000000383.

PMID:
29474241
27.

The Novel Fungal Cyp51 Inhibitor VT-1598 Is Efficacious in Experimental Models of Central Nervous System Coccidioidomycosis Caused by Coccidioides posadasii and Coccidioides immitis.

Wiederhold NP, Shubitz LF, Najvar LK, Jaramillo R, Olivo M, Catano G, Trinh HT, Yates CM, Schotzinger RJ, Garvey EP, Patterson TF.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02258-17. doi: 10.1128/AAC.02258-17. Print 2018 Apr.

28.

Multi-locus sequence typing provides epidemiological insights for diseased sharks infected with fungi belonging to the Fusarium solani species complex.

Desoubeaux G, Debourgogne A, Wiederhold NP, Zaffino M, Sutton D, Burns RE, Frasca S Jr, Hyatt MW, Cray C.

Med Mycol. 2018 Jul 1;56(5):591-601. doi: 10.1093/mmy/myx089.

PMID:
29420818
29.

Fungal-specific Cyp51 inhibitor VT-1598 demonstrates in vitro activity against Candida and Cryptococcus species, endemic fungi, including Coccidioides species, Aspergillus species and Rhizopus arrhizus.

Wiederhold NP, Patterson HP, Tran BH, Yates CM, Schotzinger RJ, Garvey EP.

J Antimicrob Chemother. 2018 Feb 1;73(2):404-408. doi: 10.1093/jac/dkx410.

PMID:
29190379
30.

Oral glucan synthase inhibitor SCY-078 is effective in an experimental murine model of invasive candidiasis caused by WT and echinocandin-resistant Candida glabrata.

Wiederhold NP, Najvar LK, Jaramillo R, Olivo M, Pizzini J, Catano G, Patterson TF.

J Antimicrob Chemother. 2018 Feb 1;73(2):448-451. doi: 10.1093/jac/dkx422.

31.

Fungal Planet description sheets: 558-624.

Crous PW, Wingfield MJ, Burgess TI, Hardy GESJ, Barber PA, Alvarado P, Barnes CW, Buchanan PK, Heykoop M, Moreno G, Thangavel R, van der Spuy S, Barili A, Barrett S, Cacciola SO, Cano-Lira JF, Crane C, Decock C, Gibertoni TB, Guarro J, Guevara-Suarez M, Hubka V, Kolařík M, Lira CRS, Ordoñez ME, Padamsee M, Ryvarden L, Soares AM, Stchigel AM, Sutton DA, Vizzini A, Weir BS, Acharya K, Aloi F, Baseia IG, Blanchette RA, Bordallo JJ, Bratek Z, Butler T, Cano-Canals J, Carlavilla JR, Chander J, Cheewangkoon R, Cruz RHSF, da Silva M, Dutta AK, Ercole E, Escobio V, Esteve-Raventós F, Flores JA, Gené J, Góis JS, Haines L, Held BW, Jung MH, Hosaka K, Jung T, Jurjević Ž, Kautman V, Kautmanova I, Kiyashko AA, Kozanek M, Kubátová A, Lafourcade M, La Spada F, Latha KPD, Madrid H, Malysheva EF, Manimohan P, Manjón JL, Martín MP, Mata M, Merényi Z, Morte A, Nagy I, Normand AC, Paloi S, Pattison N, Pawłowska J, Pereira OL, Petterson ME, Picillo B, Raj KNA, Roberts A, Rodríguez A, Rodríguez-Campo FJ, Romański M, Ruszkiewicz-Michalska M, Scanu B, Schena L, Semelbauer M, Sharma R, Shouche YS, Silva V, Staniaszek-Kik M, Stielow JB, Tapia C, Taylor PWJ, Toome-Heller M, Vabeikhokhei JMC, van Diepeningen AD, Van Hoa N, M VT, Wiederhold NP, Wrzosek M, Zothanzama J, Groenewald JZ.

Persoonia. 2017 Jun;38:240-384. doi: 10.3767/003158517X698941. Epub 2017 Jun 20.

32.

Antifungal resistance: current trends and future strategies to combat.

Wiederhold NP.

Infect Drug Resist. 2017 Aug 29;10:249-259. doi: 10.2147/IDR.S124918. eCollection 2017. Review.

33.

Culture-Independent Molecular Methods for Detection of Antifungal Resistance Mechanisms and Fungal Identification.

Perlin DS, Wiederhold NP.

J Infect Dis. 2017 Aug 15;216(suppl_3):S458-S465. doi: 10.1093/infdis/jix121.

PMID:
28911041
34.

The antifungal arsenal: alternative drugs and future targets.

Wiederhold NP.

Int J Antimicrob Agents. 2018 Mar;51(3):333-339. doi: 10.1016/j.ijantimicag.2017.09.002. Epub 2017 Sep 7. Review.

PMID:
28890395
35.

Dynamics of Mixed- Candida Species Biofilms in Response to Antifungals.

Vipulanandan G, Herrera M, Wiederhold NP, Li X, Mintz J, Wickes BL, Kadosh D.

J Dent Res. 2018 Jan;97(1):91-98. doi: 10.1177/0022034517729351. Epub 2017 Aug 29.

36.

PHARMACOKINETICS OF ORALLY ADMINISTERED VORICONAZOLE IN AFRICAN PENGUINS (SPHENISCUS DEMERSUS) AFTER SINGLE AND MULTIPLE DOSES.

Hyatt MW, Wiederhold NP, Hope WW, Stott KE.

J Zoo Wildl Med. 2017 Jun;48(2):352-362. doi: 10.1638/2016-0160R2.1.

PMID:
28749255
37.

Multiple Brain Abscesses Caused by Trichosporon inkin in a Patient with X-Linked Chronic Granulomatous Disease (CGD) Successfully Treated with Antifungal Therapy.

Hajjar J, Restrepo A, Javeri H, Wiederhold NP, Papanastassiou AM, Patterson TF.

J Clin Immunol. 2017 Aug;37(6):519-523. doi: 10.1007/s10875-017-0419-1. Epub 2017 Jul 11. No abstract available.

PMID:
28698914
38.

Prophylactic Treatment with VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus Infection.

Gebremariam T, Alkhazraji S, Lin L, Wiederhold NP, Garvey EP, Hoekstra WJ, Schotzinger RJ, Patterson TF, Filler SG, Ibrahim AS.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e00390-17. doi: 10.1128/AAC.00390-17. Print 2017 Sep.

39.

Loss of C-5 Sterol Desaturase Activity Results in Increased Resistance to Azole and Echinocandin Antifungals in a Clinical Isolate of Candida parapsilosis.

Rybak JM, Dickens CM, Parker JE, Caudle KE, Manigaba K, Whaley SG, Nishimoto AT, Luna-Tapia A, Roy S, Zhang Q, Barker KS, Palmer GE, Sutter TR, Homayouni R, Wiederhold NP, Kelly SL, Rogers PD.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e00651-17. doi: 10.1128/AAC.00651-17. Print 2017 Sep.

40.

Diversity of Veronaea botryosa from different hosts and evaluation of laboratory challenge models for phaeohyphomycosis in Acipenser transmontanus.

Soto E, Richey C, Reichley SR, Stevens B, Kenelty KV, Lewis J, Byrne B, Wiederhold NP, Waltzek TB, Sheley MF, Camus AC, Griffin MJ.

Dis Aquat Organ. 2017 Jun 19;125(1):7-18. doi: 10.3354/dao03134.

PMID:
28627488
41.

[A case of coccidioidomycosis in Turkey imported from the United States of America].

Başaran S, Karabıçak N, Şimşek Yavuz S, Wiederhold NP, Şafak S, Sarıbuğa A, Sutton DA, Bingöl Z, Çağatay A, Özsüt H, Kılıçaslan Z, Eraksoy H.

Mikrobiyol Bul. 2017 Apr;51(2):183-190. Turkish.

42.

The Tetrazole VT-1161 Is a Potent Inhibitor of Trichophyton rubrum through Its Inhibition of T. rubrum CYP51.

Warrilow AGS, Parker JE, Price CL, Garvey EP, Hoekstra WJ, Schotzinger RJ, Wiederhold NP, Nes WD, Kelly DE, Kelly SL.

Antimicrob Agents Chemother. 2017 Jun 27;61(7). pii: e00333-17. doi: 10.1128/AAC.00333-17. Print 2017 Jul.

43.

Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans.

Wiederhold NP, Law D, Birch M.

J Antimicrob Chemother. 2017 Jul 1;72(7):1977-1980. doi: 10.1093/jac/dkx065.

PMID:
28333310
44.

Fungal Keratitis Secondary to Trametes betulina: A Case Report and Review of Literature.

Hardin JS, Sutton DA, Wiederhold NP, Mele J, Goyal S.

Mycopathologia. 2017 Aug;182(7-8):755-759. doi: 10.1007/s11046-017-0128-6. Epub 2017 Mar 21. Review.

PMID:
28324243
45.

Prophylaxis with Isavuconazole or Posaconazole Protects Immunosuppressed Mice from Pulmonary Mucormycosis.

Gebremariam T, Alkhazraji S, Baldin C, Kovanda L, Wiederhold NP, Ibrahim AS.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e02589-16. doi: 10.1128/AAC.02589-16. Print 2017 May.

46.

Fungal Planet description sheets: 469-557.

Crous PW, Wingfield MJ, Burgess TI, Hardy GE, Crane C, Barrett S, Cano-Lira JF, Le Roux JJ, Thangavel R, Guarro J, Stchigel AM, Martín MP, Alfredo DS, Barber PA, Barreto RW, Baseia IG, Cano-Canals J, Cheewangkoon R, Ferreira RJ, Gené J, Lechat C, Moreno G, Roets F, Shivas RG, Sousa JO, Tan YP, Wiederhold NP, Abell SE, Accioly T, Albizu JL, Alves JL, Antoniolli ZI, Aplin N, Araújo J, Arzanlou M, Bezerra JD, Bouchara JP, Carlavilla JR, Castillo A, Castroagudín VL, Ceresini PC, Claridge GF, Coelho G, Coimbra VR, Costa LA, da Cunha KC, da Silva SS, Daniel R, de Beer ZW, Dueñas M, Edwards J, Enwistle P, Fiuza PO, Fournier J, García D, Gibertoni TB, Giraud S, Guevara-Suarez M, Gusmão LF, Haituk S, Heykoop M, Hirooka Y, Hofmann TA, Houbraken J, Hughes DP, Kautmanová I, Koppel O, Koukol O, Larsson E, Latha KP, Lee DH, Lisboa DO, Lisboa WS, López-Villalba Á, Maciel JL, Manimohan P, Manjón JL, Marincowitz S, Marney TS, Meijer M, Miller AN, Olariaga I, Paiva LM, Piepenbring M, Poveda-Molero JC, Raj KN, Raja HA, Rougeron A, Salcedo I, Samadi R, Santos TA, Scarlett K, Seifert KA, Shuttleworth LA, Silva GA, Silva M, Siqueira JP, Souza-Motta CM, Stephenson SL, Sutton DA, Tamakeaw N, Telleria MT, Valenzuela-Lopez N, Viljoen A, Visagie CM, Vizzini A, Wartchow F, Wingfield BD, Yurchenko E, Zamora JC, Groenewald JZ.

Persoonia. 2016 Dec;37:218-403. doi: 10.3767/003158516X694499. Epub 2016 Dec 21.

47.

Fatal disseminated Rasamsonia infection in cystic fibrosis post-lung transplantation.

Hong G, White M, Lechtzin N, West NE, Avery R, Miller H, Lee R, Lovari RJ, Massire C, Blyn LB, Liang X, Sutton DA, Fu J, Wickes BL, Wiederhold NP, Zhang SX.

J Cyst Fibros. 2017 Mar;16(2):e3-e7. doi: 10.1016/j.jcf.2017.01.005. Epub 2017 Feb 6.

48.

Large-Scale Evaluation of In Vitro Amphotericin B, Triazole, and Echinocandin Activity against Coccidioides Species from U.S. Institutions.

Thompson GR 3rd, Barker BM, Wiederhold NP.

Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e02634-16. doi: 10.1128/AAC.02634-16. Print 2017 Apr.

49.

The Carbohydrate Lectin Receptor Dectin-1 Mediates the Immune Response to Exserohilum rostratum.

Reedy JL, Negoro PE, Feliu M, Lord AK, Khan NS, Lukason DP, Wiederhold NP, Tam JM, Mansour MK, Patterson TF, Vyas JM.

Infect Immun. 2017 Feb 23;85(3). pii: e00903-16. doi: 10.1128/IAI.00903-16. Print 2017 Mar.

50.

Monotherapy or combination therapy of isavuconazole and micafungin for treating murine mucormycosis.

Gebremariam T, Wiederhold NP, Alqarihi A, Uppuluri P, Azie N, Edwards JE Jr, Ibrahim AS.

J Antimicrob Chemother. 2017 Feb;72(2):462-466. doi: 10.1093/jac/dkw433. Epub 2016 Oct 24.

Supplemental Content

Loading ...
Support Center